Pharmaceutical compositions of fumaric acid esters
US11135296B2 · kind B2 · utility
0Cited by
42References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2018 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | May 28, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions and dosage forms of (N,N-diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate and/or methyl 4-morpholin-4-ylbutyl (2E)but-2-ene-1,4-dioate, containing low levels of certain impurities are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.